How much does a box of ritexitinib cost?

Ritlecitinib is an oral Janus kinase (JAK) inhibitor, which mainly targets the JAK3 and TEC family kinases and is highly selective. It is used to treat Alopecia Areata, an autoimmune disease characterized by the immune system attacking hair follicles. The drug works by inhibiting key signaling pathways in immune cells, thereby reducing the immune response and helping patients restore hair regrowth.

Ritexitinib is currently on the market in China, but it has not yet been included in medical insurance. Patients can buy it domestically at a price of about more than 3,000 yuan. For specific prices, please consult the local hospital pharmacy. The foreign original drugs are mainly the European version, with a price of more than 10,000 yuan; the cheaper foreign version is the Lao version of the generic drug, with a price of more than 1,000 yuan, and the ingredients are basically the same as the original drugs.

In clinical trials, ritixitinib demonstrated significant efficacy, especially in patients with moderate to severe alopecia areata. Its mechanism of action is to block the JAK-STAT signaling pathway, thereby reducing the attack of immune cells such as T cells on hair follicles, protecting hair follicle function and promoting hair regeneration. Trial results showed that after 24 weeks of treatment, many patients experienced significant increases in hair coverage and were well tolerated.

Common adverse reactions include upper respiratory tract infection, headache, gastrointestinal discomfort, etc. Most symptoms are mild to moderate. Ritexitinib is not yet widely available in all countries and regions. Patients should consult a professional physician to evaluate the suitability of its treatment before taking the drug.

Since ritixitinib is a new type of JAK inhibitor, its launch and application provide a new treatment option for patients with alopecia areata and are expected to improve the quality of life of this type of patients. In the future, as more clinical data accumulates, its scope of application and safety are expected to be further clarified.